Picton Mahoney Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-509,142
Closed -$26.3M 854
2022
Q3
$26.3M Buy
+509,142
New +$21M 0.95% 13

Other funds holding CCXI

Picton Mahoney Asset Management's CCXI Position: Q4 2022 in Review

Picton Mahoney Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 509,142 shares — an estimated $26.3M sold.

Picton Mahoney Asset Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $26.3M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Picton Mahoney Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 509,142 ChemoCentryx, Inc. shares in Q4 2022, an estimated $26.3M.
  • Picton Mahoney Asset Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Picton Mahoney Asset Management's ChemoCentryx, Inc. position peaked at $26.3M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.